Joachim Brom Selected Research

certoparin (certoparin sodium)

1/2006	Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial.
12/2003	Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients.
10/2003	Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
8/2003	Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joachim Brom Research Topics

Disease

4	Hemorrhage 01/2006 - 08/2003
2	Venous Thromboembolism 12/2003 - 10/2003
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2003 - 08/2003
2	Body Weight (Weight, Body) 10/2003 - 08/2003
1	Stroke (Strokes) 01/2006
1	Ischemic Stroke 01/2006
1	Thromboembolism 12/2003

Drug/Important Bio-Agent (IBA)

4	certoparin (certoparin sodium)IBA 01/2006 - 08/2003
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2006 - 08/2003
3	Heparin (Liquaemin)FDA LinkGeneric 01/2006 - 08/2003

Therapy/Procedure

1	Replacement Arthroplasty 12/2003
1	Orthopedic Procedures 12/2003